{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:36:23Z","timestamp":1787646983848,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00405-025-09616-1","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T19:18:20Z","timestamp":1758655100000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of bevacizumab as an adjuvant to surgery in recurrent laryngeal papillomatosis: a systematic review of recurrence event outcomes"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5662-3553","authenticated-orcid":false,"given":"Christian Eliud Galindo","family":"Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-4249","authenticated-orcid":false,"given":"Victor Roman Sanchez","family":"Balderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4131-093X","authenticated-orcid":false,"given":"Juan Manuel Shiguetomi","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fernandez","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9 Reyes","family":"Fortanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo Josue Rangel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"1","key":"9616_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/lio2.242","volume":"4","author":"T Kurita","year":"2019","unstructured":"Kurita T, Chitose S-I, Sato K, Sakazaki T, Fukahori M, Sueyoshi S et al (2019) Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics: pathological mechanisms of laryngeal papillomatosis. Laryngoscope Investig Otolaryngol [Internet] 4(1):89\u201394","journal-title":"Laryngoscope Investig Otolaryngol [Internet]"},{"issue":"5","key":"9616_CR2","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3892\/ol.2014.2486","volume":"8","author":"M Mohr","year":"2014","unstructured":"Mohr M, Schliemann C, Biermann C, Schmidt L-H, Kessler T, Schmidt J et al (2014) Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett [Internet] 8(5):1912\u20131918","journal-title":"Oncol Lett [Internet]"},{"issue":"3","key":"9616_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.17219\/acem\/67461","volume":"26","author":"K Nowi\u0144ska","year":"2017","unstructured":"Nowi\u0144ska K, Ciesielska U, Podhorska-Oko\u0142\u00f3w M, Dzi\u0119giel P (2017) The role of human papillomavirus in oncogenic transformation and its contribution to the etiology of precancerous lesions and cancer of the larynx: A review. Adv Clin Exp Med [Internet] 26(3):539\u2013547","journal-title":"Adv Clin Exp Med [Internet]"},{"issue":"4","key":"9616_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hed.21421","volume":"33","author":"MC Torrente","year":"2011","unstructured":"Torrente MC, Rodrigo JP, Haigentz M Jr, Dikkers FG, Rinaldo A, Takes RP et al (2011) Human papillomavirus infections in laryngeal cancer. Head Neck [Internet] 33(4):581\u2013586","journal-title":"Head Neck [Internet]"},{"issue":"2","key":"9616_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2011.06.012","volume":"161","author":"C-M Ho","year":"2011","unstructured":"Ho C-M, Lee B-H, Chang S-F, Chien T-Y, Huang S-H, Yan C-C et al (2011) Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Res [Internet] 161(2):124\u2013130","journal-title":"Virus Res [Internet]"},{"issue":"23","key":"9616_CR6","doi-asserted-by":"publisher","first-page":"12162","DOI":"10.1128\/JVI.76.23.12162-12172.2002","volume":"76","author":"K Kabsch","year":"2002","unstructured":"Kabsch K, Alonso A (2002) The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol [Internet] 76(23):12162\u201312172","journal-title":"J Virol [Internet]"},{"issue":"1","key":"9616_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.virol.2009.07.034","volume":"393","author":"L Hu","year":"2009","unstructured":"Hu L, Ceresa BP (2009) Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion. Virol [Internet] 393(1):135\u2013143","journal-title":"Virol [Internet]"},{"issue":"4","key":"9616_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/000348940511400407","volume":"114","author":"R Rahbar","year":"2005","unstructured":"Rahbar R, Vargas SO, Folkman J, McGill TJ, Healy GB, Tan X et al (2005) Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol [Internet] 114(4):289\u2013295","journal-title":"Ann Otol Rhinol Laryngol [Internet]"},{"issue":"10","key":"9616_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/000348941112001001","volume":"120","author":"SM Zeitels","year":"2011","unstructured":"Zeitels SM, Barbu AM, Landau-Zemer T, Lopez-Guerra G, Burns JA, Friedman AD et al (2011) Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol [Internet] 120(10):627\u2013634","journal-title":"Ann Otol Rhinol Laryngol [Internet]"},{"issue":"4","key":"9616_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.otc.2019.03.011","volume":"52","author":"CS Derkay","year":"2019","unstructured":"Derkay CS, Bluher AE (2019) Update on recurrent respiratory papillomatosis. Otolaryngol Clin North Am [Internet] 52(4):669\u2013679","journal-title":"Otolaryngol Clin North Am [Internet]"},{"key":"9616_CR11","doi-asserted-by":"crossref","unstructured":"Sidell DR, Balakrishnan K, Best SR, Zur K, Buckingham J, De Alarcon A, Baroody FM, Bock JM, Boss EF, Bower CM, Campisi P, Chen SF, Clarke JM, Clarke KD, Cocciaglia A, Cotton RT, Cuestas G, Davis KL, DeFago VH, Dikkers FG, Derkay CS (2021) Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement. The Laryngoscope 131(6):E1941-E1949","DOI":"10.1002\/lary.29343"},{"key":"9616_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/TCRM.S81825","volume":"11","author":"M Carifi","year":"2015","unstructured":"Carifi M, Napolitano D, Morandi M, Dall\u2019Olio D (2015) Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag [Internet] 11:731\u2013738","journal-title":"Ther Clin Risk Manag [Internet]"},{"issue":"5","key":"9616_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/coa.12565","volume":"41","author":"MRM San Giorgi","year":"2016","unstructured":"San Giorgi MRM, van den Heuvel ER, Tjon Pian Gi REA, Brunings JW, Chirila M, Friedrich G et al (2016) Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol [Internet] 41(5):448\u2013453","journal-title":"Clin Otolaryngol [Internet]"},{"issue":"5","key":"9616_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/lary.28139","volume":"130","author":"S Tam","year":"2020","unstructured":"Tam S, Wu C-F, Peng H-L, Dahlstrom KR, Sturgis EM, Lairson DR (2020) Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients. Laryngoscope [Internet] 130(5):1186\u20131194","journal-title":"Laryngoscope [Internet]"},{"issue":"14","key":"9616_CR15","doi-asserted-by":"publisher","first-page":"8716","DOI":"10.3390\/ijerph19148716","volume":"19","author":"C Saraniti","year":"2022","unstructured":"Saraniti C, Gallina S, Verro B (2022) NBI and laryngeal papillomatosis: A diagnostic challenge: A systematic review. Int J Environ Res Public Health [Internet] 19(14):8716","journal-title":"Int J Environ Res Public Health [Internet]"},{"issue":"Suppl 3","key":"9616_CR16","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1007\/s12070-021-02814-3","volume":"74","author":"A Goyal","year":"2022","unstructured":"Goyal A, Kapoor D, Saha R (2022) Systemic and intralesional bevacizumab in juvenile onset recurrent respiratory papillomatosis: A report of two cases. Indian J Otolaryngol Head Neck Surg [Internet] 74(Suppl 3):5098\u20135101","journal-title":"Indian J Otolaryngol Head Neck Surg [Internet]"},{"key":"9616_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/PHMT.S200186","volume":"11","author":"RY Seedat","year":"2020","unstructured":"Seedat RY (2020) Juvenile-onset recurrent respiratory papillomatosis diagnosis and management - A developing country review. Pediatr Health Med Ther [Internet] 11:39\u201346","journal-title":"Pediatr Health Med Ther [Internet]"},{"key":"9616_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet] 372:n71","journal-title":"BMJ [Internet]"},{"issue":"10","key":"9616_CR19","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/lary.26662","volume":"127","author":"SR Best","year":"2017","unstructured":"Best SR, Mohr M, Zur KB (2017) Systemic bevacizumab for recurrent respiratory papillomatosis: A National survey. Laryngoscope [Internet] 127(10):2225\u20132229","journal-title":"Laryngoscope [Internet]"},{"issue":"2","key":"9616_CR20","first-page":"82","volume":"73","author":"Y Ablanedo-Terrazas","year":"2021","unstructured":"Ablanedo-Terrazas Y, Estrada-Camacho O, Alvarado-de la Barrera C, Ram\u00edrez-Garc\u00eda A, Tona-Acedo G, Bross-Soriano D et al (2021) Efficacy of Cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study. Acta Otorhinolaryngol (Engl Ed) [Internet] 73(2):82\u201388","journal-title":"Acta Otorhinolaryngol (Engl Ed) [Internet]"},{"issue":"1","key":"9616_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.17843\/rpmesp.2023.401.12169","volume":"40","author":"E Zumaeta-Saavedra","year":"2023","unstructured":"Zumaeta-Saavedra E, Chiara-Chilet C, Maquera-Afaray J, Luna-Vilchez M (2023) Recurrent laryngeal papillomatosis with pulmonary involvement: case report. Rev Peru Med Exp Salud Publica [Internet] 40(1):111\u2013114","journal-title":"Rev Peru Med Exp Salud Publica [Internet]"},{"key":"9616_CR22","doi-asserted-by":"publisher","first-page":"8847436","DOI":"10.1155\/2021\/8847436","volume":"2021","author":"U Muhammad","year":"2021","unstructured":"Muhammad U, Shaffer M, Bishara J (2021) The Tale of stridor and wheezing in an infant. Case Rep Pediatr [Internet] 2021:8847436","journal-title":"Case Rep Pediatr [Internet]"},{"issue":"Suppl 1","key":"9616_CR23","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.14639\/0392-100X-suppl.1-43-2023-14","volume":"43","author":"G Bertino","year":"2023","unstructured":"Bertino G, Pedretti F, Mauramati S, Filauro M, Vallin A, Mora F et al (2023) Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study. Acta Otorhinolaryngol Ital [Internet] 43(Suppl 1):S111\u2013S122","journal-title":"Acta Otorhinolaryngol Ital [Internet]"},{"issue":"2","key":"9616_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.18004\/anales\/2022.055.02.68","volume":"55","author":"FA Pires Cardozo","year":"2022","unstructured":"Pires Cardozo FA, Mena Canata C, Ortiz Bogado JL, Tornaco Maidana R (2022) Therapeutic results of recurrent respiratory papillomatosis in otorhinolaryngology hospital de cl\u00ednicas period 2005 to 2020. Fac Cienc Med (Asuncion) 55(2):68\u201381","journal-title":"Fac Cienc Med (Asuncion)"},{"issue":"3","key":"9616_CR25","first-page":"E921","volume":"131","author":"A Tkaczuk","year":"2021","unstructured":"Tkaczuk A, Trivedi S, Mody MD, Steuer CE, Shin DM, Klein AM et al (2021) Parenteral bevacizumab for the treatment of severe respiratory papillomatosis in an adult population. Laryngoscope [Internet] 131(3):E921\u2013E928","journal-title":"Laryngoscope [Internet]"},{"issue":"4","key":"9616_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/lary.27674","volume":"129","author":"C Carnevale","year":"2019","unstructured":"Carnevale C, Ferr\u00e1n-De la Cierva L, Til-P\u00e9rez G, Pe\u00f1a-Zarza JA, Osona-Rodriguez B, Martinez-Lozano J et al (2019) Safe use of systemic bevacizumab for respiratory recurrent papillomatosis in two children: bevacizumab and respiratory papillomatosis. Laryngoscope [Internet] 129(4):1001\u20131004","journal-title":"Laryngoscope [Internet]"},{"issue":"11","key":"9616_CR27","first-page":"1737","volume":"26","author":"AH Hamza","year":"2005","unstructured":"Hamza AH, Nasr MM, Deghady AA (2005) The use of mitomycin-C for respiratory papillomas:clinical, histologic and biochemical correlation. Saudi Med J. 26(11):1737\u201345","journal-title":"Saudi Med J."},{"issue":"5","key":"9616_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00405-013-2755-y","volume":"271","author":"M Chiril\u0103","year":"2014","unstructured":"Chiril\u0103 M, Bolboac\u0103 SD (2014) Clinical efficiency of quadrivalent HPV (types 6\/11\/16\/18) vaccine in patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol [Internet]. 271(5):1135\u201342","journal-title":"Eur Arch Otorhinolaryngol [Internet]."},{"issue":"7","key":"9616_CR29","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/lary.26450","volume":"127","author":"KB Zur","year":"2017","unstructured":"Zur KB, Fox E (2017) Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child. Laryngoscope [Internet] 127(7):1538\u20131542","journal-title":"Laryngoscope [Internet]"},{"issue":"9","key":"9616_CR30","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1007\/s00405-022-07388-6","volume":"279","author":"L Pogoda","year":"2022","unstructured":"Pogoda L, Ziylan F, Smeeing DPJ, Dikkers FG, Rinkel RNPM (2022) Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review. Eur Arch Otorhinolaryngol [Internet] 279(9):4229\u20134240","journal-title":"Eur Arch Otorhinolaryngol [Internet]"},{"issue":"2","key":"9616_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s12070-022-03204-z","volume":"75","author":"R Guragain","year":"2023","unstructured":"Guragain R, Gyawali BR (2023) Intralesional bevacizumab as adjuvant therapy for juvenile onset recurrent respiratory papillomatosis: A systematic review. Indian J Otolaryngol Head Neck Surg [Internet] 75(2):1296\u20131301","journal-title":"Indian J Otolaryngol Head Neck Surg [Internet]"},{"issue":"2","key":"9616_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00405-023-08279-0","volume":"281","author":"FH Zagzoog","year":"2024","unstructured":"Zagzoog FH, Mogharbel AM, Alqutub A, Bukhari M, Almohizea MI (2024) Intralesional Cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis. Eur Arch Otorhinolaryngol [Internet] 281(2):601\u2013627","journal-title":"Eur Arch Otorhinolaryngol [Internet]"},{"issue":"10","key":"9616_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/00034894241264388","volume":"133","author":"UE Gately","year":"2024","unstructured":"Gately UE, Zhang N, Karle WE, Lott DG (2024) Adjuvant intralesional bevacizumab in pediatric and adult populations with recurrent respiratory papillomatosis: A systematic review. Ann Otol Rhinol Laryngol [Internet] 133(10):841\u2013847","journal-title":"Ann Otol Rhinol Laryngol [Internet]"},{"issue":"2","key":"9616_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/lary.30893","volume":"134","author":"RJ So","year":"2024","unstructured":"So RJ, Hidalgo Lopez JC, Ballestas SA, Klein AM, Steuer C, Shin DM et al (2024) Efficacy of systemic bevacizumab for recurrent respiratory papillomatosis with pulmonary involvement. Laryngoscope [Internet] 134(2):577\u2013581","journal-title":"Laryngoscope [Internet]"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09616-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:22:53Z","timestamp":1773393773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09616-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9616"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09616-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}